Takayuki Yamamoto

17PUBLICATIONS
40CO-AUTHORS
GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Clinical nutritionAutoimmunityCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 28, 2026
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study).

|Jun 29, 2026
When nothing else matters: proctectomy for complex perianal Crohn's disease-indications, timing, techniques, and outcomes.

|Apr 29, 2026
Exploring the efficacy and future prospects of nutritional and dietary therapies in Crohn's disease.

|Feb 04, 2026
Leucine-rich alpha-2 glycoprotein as a blood biomarker in inflammatory bowel disease: clinical implications and future perspectives.

Takayuki Yamamoto

|Mar 03, 2025
Clinical features by disease duration in ulcerative colitis-associated cancers.

Hiroshi Miyakita, Seiichiro Yamamoto, Motoi Uchino

|May 04, 2023
Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study.

Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Yohei Mikami

Pageof 3

Frequent Collaborators

4 joint publications

Paulo Gustavo Kotze

2 joint publications

Katsuyoshi Matsuoka

2 joint publications

Tadakazu Hisamatsu

2 joint publications

Shinichiro Shinzaki